These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 3106496

  • 1. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
    Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ, Cohn ZA.
    J Immunol; 1987 May 01; 138(9):3028-34. PubMed ID: 3106496
    [Abstract] [Full Text] [Related]

  • 2. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA.
    J Immunol; 1986 Jun 01; 136(11):4255-63. PubMed ID: 2422278
    [Abstract] [Full Text] [Related]

  • 3. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH, Converse PJ, Gebre N, Wondimu A, Ehrenberg JP, Kiessling R.
    Eur J Immunol; 1989 Apr 01; 19(4):707-13. PubMed ID: 2659369
    [Abstract] [Full Text] [Related]

  • 4. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH.
    J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851
    [Abstract] [Full Text] [Related]

  • 5. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ, Closs O, Belehu A.
    Int J Lepr Other Mycobact Dis; 1982 Dec 15; 50(4):455-67. PubMed ID: 6763003
    [Abstract] [Full Text] [Related]

  • 6. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS.
    Int J Lepr Other Mycobact Dis; 1996 Sep 15; 64(3):257-67. PubMed ID: 8862259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
    Bach MA, Wallach D, Flageul B, Cottenot F.
    Clin Exp Immunol; 1983 Apr 15; 52(1):107-14. PubMed ID: 6345031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H, Schoel B, Chiplunkar S, Gangal S, Deo MG, Kaufmann SH.
    Int J Lepr Other Mycobact Dis; 1992 Mar 15; 60(1):44-53. PubMed ID: 1602193
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanisms of T-cell unresponsiveness in leprosy.
    Bach MA, Hoffenbach A, Lagrange PH, Wallach D, Cottenot F.
    Ann Immunol (Paris); 1983 Mar 15; 134D(1):75-84. PubMed ID: 6226239
    [Abstract] [Full Text] [Related]

  • 15. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG.
    J Immunol; 1985 Aug 15; 135(2):1443-9. PubMed ID: 2989366
    [Abstract] [Full Text] [Related]

  • 16. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
    Chattree V, Khanna N, Rao DN.
    Mol Immunol; 2007 Mar 15; 44(8):2066-77. PubMed ID: 17046060
    [Abstract] [Full Text] [Related]

  • 17. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL, Kato H, Mehra V, Nelson EE, Fan XD, Rea TH, Pattengale PK, Bloom BR.
    Nature; 2007 Mar 15; 322(6078):459-61. PubMed ID: 2942780
    [Abstract] [Full Text] [Related]

  • 18. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U, Sinha S, Ramu G, Lamb J, Ivanyi J.
    Clin Exp Immunol; 1987 Apr 15; 68(1):58-64. PubMed ID: 3308210
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1997 Jun 15; 65(2):178-89. PubMed ID: 9251589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.